Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,546 | -32,522 | -110,212 | -75,196 | -50,860 |
| Depreciation Amortization | 755 | 393 | 1,538 | 1,137 | 764 |
| Accounts receivable | -2 | 15 | 239 | -5,938 | 202 |
| Accounts payable and accrued liabilities | 4,600 | 1,913 | 341 | -1,266 | -980 |
| Other Working Capital | 2,865 | -3,863 | 1,735 | -9,179 | -5,180 |
| Other Operating Activity | 1,180 | 829 | 9,988 | 15,047 | 5,904 |
| Operating Cash Flow | $-51,148 | $-33,235 | $-96,371 | $-75,395 | $-50,150 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 59,706 | 17,415 | -164,790 | -197,776 | -199,441 |
| PPE Investments | -683 | -118 | -624 | -420 | -319 |
| Investing Cash Flow | $59,023 | $17,297 | $-165,414 | $-198,196 | $-199,760 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -303 | -150 | -561 | -416 | -274 |
| Common Stock Issued | 3,062 | 2,574 | 132,401 | 132,086 | 131,715 |
| Other Financing Activity | 0 | 0 | -483 | -374 | -374 |
| Financing Cash Flow | $2,759 | $2,424 | $131,357 | $131,296 | $131,067 |
| Beginning Cash Position | 78,357 | 78,357 | 208,785 | 208,323 | 208,323 |
| End Cash Position | 88,991 | 64,843 | 78,357 | 66,028 | 89,480 |
| Net Cash Flow | $10,634 | $-13,514 | $-130,428 | $-142,295 | $-118,843 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,148 | -33,235 | -96,371 | -75,395 | -50,150 |
| Capital Expenditure | -683 | -118 | -624 | -420 | -319 |
| Free Cash Flow | -51,831 | -33,353 | -96,995 | -75,815 | -50,469 |